Mycosis fungoides associated with B-cell malignancies

British Journal of Dermatology

Volumn 155, Issue 2, 2006, Pages 379-386

  Barzilai, A ^a,b   Trau, H ^a,b   David, M ^c   Feinmesser, M ^b,c   Bergman, R ^d   Shpiro, D ^a,b   Schiby, G ^a,b   Rosenblatt, K ^a,b   Or, R ^e   Hodak, E ^c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

B cell malignancy; Composite lymphoma; Cutaneous T cell lymphoma; Discordant lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERFERON; MESNA; METHOTREXATE; MITOXANTRONE; PSORALEN; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER INFILTRATION; CANCER PATIENT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; LARGE CELL LYMPHOMA; MALE; MALIGNANT TRANSFORMATION; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; PATIENT SELECTION; PRIORITY JOURNAL; PUVA; SAMPLE SIZE; SKIN BIOPSY; SKIN LYMPHOMA; T LYMPHOCYTE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HODGKIN DISEASE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS;

EID: 33745876299     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07346.x     Document Type: Article

References (45)

1. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphomas, Summary and Description of a Working Formulation for Clinical Usage. Cancer 1982; 49:2112-35.
2. Kim H. Composite lymphoma and related disorders. Am J Clin Pathol 1993; 99:445-51.
3. Sheibani K, Forman SJ, Weinberg CD, Rappaport H. Coincidence of B-cell chronic lymphocytic leukemia and cutaneous T-cell lymphoma (mycosis fungoides): immunologic characterization by monoclonal antibodies. Blood 1983; 62:1176-81.
4. Aberer W, Groh V, Bettelheim P et al. T- und B-zell doppellymphom: immunologische charakterisierung mittles monoklinaler antikorper. Hautartz 1988; 39:388-92.
5. Allué L, Domingo A, Moreno A et al. Simultaneous occurrence of cutaneous T-cell lymphoma and low-grade B-cell lymphoproliferative disease: a report of two cases. J Am Acad Dermatol 1990; 23:677-81.
6. Harland CC, Whittaker SJ, Ng YL et al. Coexistent cutaneous T-cell lymphoma and B-cell chronic lymphocytic leukaemia. Br J Dermatol 1992; 127:519-23.
7. Liu YC, Tomashefski JF Jr, Cleavland RP et al. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol 1994; 7:641-6.
8. Grange F, Avril M-F, Esteve E et al. Coexistent cutaneous T-cell lymphoma and B-cell malignancy. J Am Acad Dermatol 1994; 31:724-31.
9. Hull PR, Saxena A. Mycosis fungoides and chronic lymphocytic leukemia - composite T-cell and B-cell lymphoma presenting in the skin. Br J Dermatol 2000; 143:439-44.
10. Volk AL, Vannucci SA, Cook W et al. Composite mycosis fungoides and B-cell chronic lymphocytic leukemia. Ann Diagn Pathol 2002; 6:172-82.
11. Konstantopoulos K, Kapsimalis V, Vaiopoulos G et al. Simultaneous appearance of mycosis fungoides and chronic lymphocytic leukemia in the same patient. Haematologia (Budap) 2000; 30:41-3.
12. Peterman A, Jerdan M, Staal S et al. Evidence of HTLV-1 associated with mycosis fungoides and B-cell chronic lymphocytic leukemia. Arch Dermatol 1986; 122:568-71.
13. Dereure O, Basset-Seguin N, Guilhou JJ. Mycosis fungoides succecdant a un lymphome non-Hodgkinien cutane B. Ann Dermatol Venereol 1993; 120:625-7.
14. Kikuchi A, Anzai H, Kosuge H et al. Aggressive B-cell lymphoma induced by Epstein-Barr virus infection in erythrodermic cutaneous T-cell lymphoma. Br J Dermatol 1997; 136:124-8.
15. Imai S, Umezu H. Cutaneous T-cell lymphoma occurring with intestinal B-cell lymphoma. Br J Dermatol 1999; 140:972-3.
16. Van der Akker TW, Van der Willigen AH, Van der Kwast TH, Van Dongen JJM. Cutaneous T cell lymphoma after successful treatment of follicular B-cell lymphoma. Br J Dermatol 1990; 123:266-7.
17. Cassuto JP, Kövary PM, Campagni JP et al. Mycosis fungoides associated with Mediterranean lymphoma. Arch Dermatol Res 1981; 270:17-23.
18. Castanet J, Lacour JP, Taillian B et al. Mycosis fongoïde survenant au cours d'un lymphome B. Ann Dermatol Venereol 1992; 119:205-8.
19. Bryant E, Ronan SG, Iossifedes IA. Plasma cell myeloma in a patient with cutaneous T-cell lymphoma. Cancer 1982; 50:2122-5.
20. Weiss VC, Barsky GJ, Solomon LM. Cutaneous T lymphocyte lymphoma in association with multiple myeloma. Arch Dermatol 1984; 120:499-51.
21. Geerts ML, Hamers J, Schwarze EW et al. Mycosis fungoides and lymphoplasmocytoid immunocytoma in the same patient. Cancer 1984; 54:2294-9.
22. Euvrard S, Noble CP, Danitakis J et al. Brief report: successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous-cell carcinomas. N Eng J Med 1992; 327:1924-6.
23. Kantor AF, Curtis RE, Vonderheid EC et al. Risk of second malignancy after cutaneous T-cell lymphoma. Cancer 1989; 63:1612-15.
24. Paolini R, Poletti A, Ramazzina E et al. Co-existence of cutaneous T-cell lymphoma and B hairy cell leukemia. Am J Hematol 2000; 64:197-202.
25. Gernone A, Frassanito MA, Pellegrino A et al. Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic, and molecular studies. Am Hematol 2002; 81:326-31.
26. Venencie PY, Winkelmann RK, Friedman SJ et al. Monoclonal gammopathy and mycosis fungoides. Report of four cases and review of the literature. J Am Acad Dermatol 1984; 11:576-9.
27. Martinez A, Pittaluga S, Villamor N et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol 2004; 28:849-58.
28. Gibbs SDJ, Herbert KE, McCormack C et al. Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sezary syndrome. Eur J Haematol 2004; 73:447-9.
29. Ohmatsu H, Saeki H, Fujita H et al. Mycosis fungoides associated with intestinal mucosa-associated lymphoid tissue lymphoma. Int J Dermatol 2005; 44:878-80.
30. Bee CS, Blaise YP, Dunphy CH. Composite lymphoma of Hodgkin's lymphoma and mycosis fungoides: previously undescribed in the same extracutaneous site. Leuk Lymphoma 2001; 42:543-9.
31. Steinhoff M, Hummel M, Assaf C et al. Cutaneous T cell lymphoma and classic Hodgkin's lymphoma of the B cell type within a single lymph node: composite lymphoma. J Clin Pathol 2004; 57:329-31.
32. Sidwell RU, McLaughlin JE, Jones A, Whittaker SJ. Hodgkin's lymphoma in a patient with mycosis fungoides: molecular evidence for separate cellular origins. Br J Dermatol 2003; 148: 810-12.
33. Davis TH, Morton CC, Miller-Cassman R et al. Hodgkin's disease, lymphomatoid papulosis and cutaneous T-cell lymphoma derived from a T-cell clone. N Engl J Med 1992; 326:1115-22.
34. Väkevä L, Pukkala E, Ranki A. Increased risk of secondary malignancy in patients with primary cutaneous T cell lymphoma. J Invest Dermatol 2000; 115:62-5.
35. Kim YH, Liu HL, Mraz-Gernhard S et al. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical and prognostic factors and risk for disease progression. Arch Dermatol 2003; 139:857-66.
36. Willemze R, Jaffe ES, Burg G et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105:3768-85.
37. Varady E, Deak B, Molnar ZS et al. Second malignancies after treatment for Hodgkin's disease. Leuk Lymphoma 2001; 42:1275-81.
38. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004; 350:1978-88.
39. Bentham G. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales. BMJ 1996; 312:1128-31.
40. Freedman DM, Zahm SH, Dosemeci M. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study. BMJ 1997; 314:1451-5.
41. Newton R. Solar ultraviolet radiation is not a major cause of primary cutaneous non-Hodgkin's lymphoma. BMJ 1997; 314:1483-4.
42. Ramsay DL, Meller JA, Zackheim HS. Topical treatment of early cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995; 9:1031-56.
43. Kim YH. Management with topical nitrogen mustard in mycosis fungoides. Dermatol Ther 2003; 16:288-98.
44. Gniadecki R. Neoplastic stem cell in cutaneous lymphomas. Evidence and clinical implications. Arch Dermatol 2004; 140:1156-9.
45. Vonderheid EC, Matsui W. Do neoplastic stem cells underlie the pathogenesis of cutaneous lymphoma? Arch Dermatol 2005; 141:641-2 (Letter).